🔥 Monday 1 June 2026 Mon, 1 June 2026

Intelligent Monitoring Group (ASX:IMB) has finalized its A$37 million purchase of Wormald NZ and Red Wolf, expanding its New Zealand footprint and projecting a 20.9% accretion in earnings per share.

Paradigm Biopharmaceuticals has successfully raised $21.375 million through an oversubscribed Share Purchase Plan and a recent placement, bolstering its balance sheet ahead of key Phase 3 trial milestones.

Magnum Mining has advanced its auger drilling campaign at the Piracanjuba North Target, completing 161 holes over 7.4 km² and preparing for key Exploration Target and JORC Resource milestones later this year.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.

Strata Minerals has secured a binding agreement with BML Ventures to fund and manage mining at its Zelica Gold Project, paving a capital-light path to production and profit sharing.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

FortifAI has appointed Kelly Herrell, a seasoned Silicon Valley CEO with a track record of scaling infrastructure tech companies to IPO and acquisition, as its new CEO. Herrell’s leadership aims to accelerate commercialisation of FortifAI’s AI Data Plane technology through its Nol8 subsidiary.

Memphasys has inked its first exclusive commercialization agreement in South-East Asia with TMSC Vietnam, targeting the fast-growing Vietnamese IVF sector with its Felix™ sperm separation system. The two-year contract, valued at A$530,000, hinges on regulatory approval expected by August 2026.

Austco Healthcare expects FY26 revenue between A$90 million and A$95 million, driven by strong sales and a significant US rollout. Net profit after tax is forecast to jump over 50%, supported by operational growth and a one-off benefit.

Coda Minerals has secured $6.7 million through an oversubscribed placement to fast-track its Pre-Feasibility Study at Elizabeth Creek, underpinning key technical and environmental programs.

Greatland Resources has locked in a $500 million debt facility with major banks, boosting liquidity to over $1.7 billion as it commits to developing its Havieron gold-copper project.

Straker Limited uncovers approximately US$4 million in fraudulent transactions at its US subsidiary, prompting forensic investigations and share trading suspension.

TG Metals has lodged a mining lease application for its Burmeister lithium deposit, targeting early-stage direct shipping ore development amid a buoyant lithium market.

Barton Gold has raised $25.5 million through an institutional placement, fully funding critical feasibility studies and resource upgrades across its Challenger, Tunkillia, and Tolmer projects in South Australia.

Nova Minerals shareholders and Nasdaq warrantholders overwhelmingly approved schemes to restructure the company under a new US holding entity, pending final court approval.

Flynn Gold has ramped up its diamond drilling program at the Firetower Gold-Tungsten Project in northern Tasmania, expanding from three to ten holes totalling 1,600 metres. The move aims to test high-grade extensions and support a maiden Mineral Resource Estimate amid critical mineral supply pressures.

Theta Gold Mines has locked in a fully subscribed US$90 million senior secured bond to complete the TGME Gold Mine Project in South Africa, targeting first gold production in early 2027.

Green & Gold Minerals (ASX: GG1) has kicked off reverse circulation drilling at Copper Hills, following rock chip assays revealing extraordinary grades of silver, copper, tin, and indium across multiple prospects within its Herberton Conductor Metals Project.

Chimeric Therapeutics reports encouraging Phase 1/2 data for its CHM CDH17 CAR-T therapy in advanced gastrointestinal cancers, with 82% of evaluable patients achieving stable disease and durable responses lasting over a year.

Jade Gas Holdings has achieved a historic milestone with Mongolia’s first-ever approval of coal seam gas reserves, unlocking the path to commercial development of its TTCBM Project in the South Gobi.

Tivan has produced 195 kg of acidgrade fluorspar at 98.6% CaF2 from its Speewah mini-pilot, exceeding the 97% market standard and setting the stage for a full pilot and offtake negotiations.

Trek Metals has marked a breakthrough year with a high-grade manganese discovery at its Christmas Creek Project in Western Australia, supported by strong assay results and expanded exploration tenure. The company bolstered its balance sheet with $19.5 million raised to fund drilling and further exploration.